Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiseng Yiqi Diwan for prevention of acute exacerbations in chronic obstructive pulmonary disease
ChiCTR-IPR-16008806Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital East Zone
- Start
- Jul 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Qishen Yiqi Diwan in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Sichuan Provincial People's Hospital East Zone. Primary endpoints: Acute exacerbation rate in 1 year and Mortality rate in 1 year. Started Jul 2016; status: recruiting.
02
Drugs
Qishen Yiqi Diwan
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-16008806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008806.